TXA in Revision Total Shoulder Arthroplasty

Arthropathy Shoulder Clinical Trial

Official title:
The Effect of Tranexamic Acid on Calculated Total Blood Loss in Patients Undergoing Revision Shoulder Arthroplasty

Status Terminated

Clinical Trial Summary

This is a phase IV, randomized, single-blind, single-center study comparing calculated total blood loss, surgical drain output and hematoma formation in patients who receive 2 doses of Tranexamic Acid (TXA) versus control group undergoing revision total shoulder arthroplasty. Patients will be randomized to either receive 2 doses of IV TXA, first dose prior to surgical incision and second dose given 3 hours later or to the control group, where no TXA will be administered.

Clinical Trial Description

The objectives of the study are to compare the effectiveness of IV TXA on reducing calculated total blood loss, surgical drain output and hematoma formation in patients undergoing revision total shoulder arthroplasty. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04650698
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Terminated
Phase	Phase 4
Start date	January 7, 2021
Completion date	March 12, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03663283` - Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty	Phase 4
Active, not recruiting	`NCT03727490` - The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty	N/A
Withdrawn	`NCT05341518` - Subscapularis Repair During Reverse Total Shoulder Arthroplasty	N/A
Completed	`NCT03735173` - Comparing the Outcome of Cemented All-Polyethylene Pegged vs. Keeled Components Through a Subscapularis Tenotomy or a Subscapularis Peel	N/A
Recruiting	`NCT04449146` - Scapular Positioning in Standing Position Using Sonography	N/A
Active, not recruiting	`NCT05499728` - Telerehabilitation After Shoulder Arthroplasty	N/A
Terminated	`NCT03599336` - RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures	N/A